Anti IL-6 domain antibodies with fatty acid substituents
US12404325B2 · kind B2 · utility
0Cited by
0References
15Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Sep 11, 2024 |
| Grant date | Sep 2, 2025 |
| Priority date | — |
| Expiry date | Sep 11, 2044 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07K2319/31
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention relates to compounds (e.g. ISVDs, polypeptides, polypeptide derivatives) capable of binding to Interleukin-6 (IL-6) and their use in the treatment of inflammatory diseases such as, e.g. cardiovascular disease (CVD).
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.